Analysts foresee less revenue Amgen

Tomorrow the American company Amgen will publish its past quarter's results. Over the current book year the total revenue will be 22,61 billion USD (consensus estimates). This is slightly lower than 2016's revenue of 22,85 billion USD.

Historical revenues and results Amgen plus estimates 2018

The analysts expect for 2018 a net profit of 9,29 billion USD. For this year the consensus of the result per share is a profit of 13,48 USD. So the price/earnings-ratio equals 12,73.

Analysts expect a dividend of 5,09 USD per share. Amgen 's dividend yield thus equals 2,97 percent. The average dividend yield of the biotech companies is a limited 1 percent.

Latest estimates around 191 USD

The most recent recommendations for the biotech company are from Barclays , Piper Jaffray and Cowen and Company.

Amgen 's market capitalization is around 126,65 billion USD.

On Thursday the stock closed at 171,56 USD.

Historical stock prices Amgen from 2007 till 2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.